68722 Role of ER calcium in beta cell senescence and diabetes pathophysiology

ABSTRACT IMPACT: The proposed study has the potential to inform new paradigms of type 1 diabetes prevention and therapy with the overall goal of improving β cell health during autoimmunity. OBJECTIVES/GOALS: Type 1 diabetes (T1D) results from immune-mediated destruction of pancreatic βcells. Recent...

Full description

Bibliographic Details
Main Authors: Staci A. Weaver, Tatsuyoshi Kono, Farooq Syed, Robert Bone, Carmella Evans-Molina
Format: Article
Language:English
Published: Cambridge University Press 2021-03-01
Series:Journal of Clinical and Translational Science
Online Access:https://www.cambridge.org/core/product/identifier/S2059866121004465/type/journal_article
_version_ 1811155360380092416
author Staci A. Weaver
Tatsuyoshi Kono
Farooq Syed
Robert Bone
Carmella Evans-Molina
author_facet Staci A. Weaver
Tatsuyoshi Kono
Farooq Syed
Robert Bone
Carmella Evans-Molina
author_sort Staci A. Weaver
collection DOAJ
description ABSTRACT IMPACT: The proposed study has the potential to inform new paradigms of type 1 diabetes prevention and therapy with the overall goal of improving β cell health during autoimmunity. OBJECTIVES/GOALS: Type 1 diabetes (T1D) results from immune-mediated destruction of pancreatic βcells. Recent data suggest that activation of senescence and acquisition of a senescence associated secretory phenotype (SASP) by βcells may contribute to T1D pathogenesis. However, the molecular mechanisms responsible for this phenotype are not well understood. METHODS/STUDY POPULATION: We hypothesize that loss of endoplasmic reticulum (ER) Ca2+ induces βcell senescence, SASP as well as mitochondrial dysfunction which drive T1D development. The current study utilizes SERCA2 KO INS-1 βcells (S2KO) exhibiting loss of ER Ca2+ and a SERCA2 haploinsufficient mice on a non-obese diabetic background (NOD-S2+/-) to test the role of ER Ca2+ loss during T1D development. Senescence associated βgalactosidase staining (SA-βgal), expression of senescence markers (RT-qPCR), mitochondrial function (Seahorse, TMRM) and mitochondrial copy number (qPCR) were all measured in S2KO versus WT βcells and are currently being measured in the NOD-S2+/- mouse model at 6, 8, 12, 14, and 16wks of age. RESULTS/ANTICIPATED RESULTS: RT-qPCR assays detecting senescence markers cdkn1a and cdkn2a and mitochondrial specific genes cox1 and nd1 were developed and validated in both INS-1 βcells and mouse islets. Mitochondrial function assay (Seahorse) was optimized for use in INS-1 βcells and is currently under development for use in intact mouse islets. S2KO βcells displayed increased SA- βgal staining as well as increased mitochondrial coupling efficiency (p=0.0146) and baseline mitochondrial copy number (p=0.0053) compared to WT βcells, suggesting a senescence phenotype and altered mitochondrial function. NOD-S2+/- mice exhibited increased expression of the senescence marker cdkn2a in the islet at 12wks (p=0.0117) compared to control mice, whereas cdkn1a remained unchanged across all timepoints tested. DISCUSSION/SIGNIFICANCE OF FINDINGS: Our results suggest that loss of SERCA2 and reduced ER Ca2+ alter βcell mitochondrial function and are associated with features of senescence. Future studies will test whether SERCA2 activation and/or senolytic/senomorphic drugs are able to prevent or delay diabetes onset in NOD-S2+/- mice.
first_indexed 2024-04-10T04:32:51Z
format Article
id doaj.art-5d308331388c4a0887c1f740f15cdd19
institution Directory Open Access Journal
issn 2059-8661
language English
last_indexed 2024-04-10T04:32:51Z
publishDate 2021-03-01
publisher Cambridge University Press
record_format Article
series Journal of Clinical and Translational Science
spelling doaj.art-5d308331388c4a0887c1f740f15cdd192023-03-10T07:52:02ZengCambridge University PressJournal of Clinical and Translational Science2059-86612021-03-015161710.1017/cts.2021.44668722 Role of ER calcium in beta cell senescence and diabetes pathophysiologyStaci A. Weaver0Tatsuyoshi Kono1Farooq Syed2Robert Bone3Carmella Evans-Molina4Indiana University School of MedicineIndiana University School of MedicineIndiana University School of MedicineIndiana University School of MedicineIndiana University School of MedicineABSTRACT IMPACT: The proposed study has the potential to inform new paradigms of type 1 diabetes prevention and therapy with the overall goal of improving β cell health during autoimmunity. OBJECTIVES/GOALS: Type 1 diabetes (T1D) results from immune-mediated destruction of pancreatic βcells. Recent data suggest that activation of senescence and acquisition of a senescence associated secretory phenotype (SASP) by βcells may contribute to T1D pathogenesis. However, the molecular mechanisms responsible for this phenotype are not well understood. METHODS/STUDY POPULATION: We hypothesize that loss of endoplasmic reticulum (ER) Ca2+ induces βcell senescence, SASP as well as mitochondrial dysfunction which drive T1D development. The current study utilizes SERCA2 KO INS-1 βcells (S2KO) exhibiting loss of ER Ca2+ and a SERCA2 haploinsufficient mice on a non-obese diabetic background (NOD-S2+/-) to test the role of ER Ca2+ loss during T1D development. Senescence associated βgalactosidase staining (SA-βgal), expression of senescence markers (RT-qPCR), mitochondrial function (Seahorse, TMRM) and mitochondrial copy number (qPCR) were all measured in S2KO versus WT βcells and are currently being measured in the NOD-S2+/- mouse model at 6, 8, 12, 14, and 16wks of age. RESULTS/ANTICIPATED RESULTS: RT-qPCR assays detecting senescence markers cdkn1a and cdkn2a and mitochondrial specific genes cox1 and nd1 were developed and validated in both INS-1 βcells and mouse islets. Mitochondrial function assay (Seahorse) was optimized for use in INS-1 βcells and is currently under development for use in intact mouse islets. S2KO βcells displayed increased SA- βgal staining as well as increased mitochondrial coupling efficiency (p=0.0146) and baseline mitochondrial copy number (p=0.0053) compared to WT βcells, suggesting a senescence phenotype and altered mitochondrial function. NOD-S2+/- mice exhibited increased expression of the senescence marker cdkn2a in the islet at 12wks (p=0.0117) compared to control mice, whereas cdkn1a remained unchanged across all timepoints tested. DISCUSSION/SIGNIFICANCE OF FINDINGS: Our results suggest that loss of SERCA2 and reduced ER Ca2+ alter βcell mitochondrial function and are associated with features of senescence. Future studies will test whether SERCA2 activation and/or senolytic/senomorphic drugs are able to prevent or delay diabetes onset in NOD-S2+/- mice.https://www.cambridge.org/core/product/identifier/S2059866121004465/type/journal_article
spellingShingle Staci A. Weaver
Tatsuyoshi Kono
Farooq Syed
Robert Bone
Carmella Evans-Molina
68722 Role of ER calcium in beta cell senescence and diabetes pathophysiology
Journal of Clinical and Translational Science
title 68722 Role of ER calcium in beta cell senescence and diabetes pathophysiology
title_full 68722 Role of ER calcium in beta cell senescence and diabetes pathophysiology
title_fullStr 68722 Role of ER calcium in beta cell senescence and diabetes pathophysiology
title_full_unstemmed 68722 Role of ER calcium in beta cell senescence and diabetes pathophysiology
title_short 68722 Role of ER calcium in beta cell senescence and diabetes pathophysiology
title_sort 68722 role of er calcium in beta cell senescence and diabetes pathophysiology
url https://www.cambridge.org/core/product/identifier/S2059866121004465/type/journal_article
work_keys_str_mv AT staciaweaver 68722roleofercalciuminbetacellsenescenceanddiabetespathophysiology
AT tatsuyoshikono 68722roleofercalciuminbetacellsenescenceanddiabetespathophysiology
AT farooqsyed 68722roleofercalciuminbetacellsenescenceanddiabetespathophysiology
AT robertbone 68722roleofercalciuminbetacellsenescenceanddiabetespathophysiology
AT carmellaevansmolina 68722roleofercalciuminbetacellsenescenceanddiabetespathophysiology